Michael S. Parmacek

Michael S. Parmacek, MD serves as the Frank Wister Thomas Professor of Medicine and Chair of the Department of Medicine at the Perelman School of Medicine, University of Pennsylvania. He previously held leadership roles including Chief of the Division of Cardiovascular Medicine (1998-2014) and Director of the University of Pennsylvania Cardiovascular Institute (2005-2017).

His academic training includes:

• Magna cum laude undergraduate degree from Tufts University
• M.D. from Northwestern University Medical School
• Internal Medicine residency at the University of Michigan
• Cardiovascular Disease fellowship at Northwestern University
• Postdoctoral research fellowship in molecular cardiology at Howard Hughes Medical Institute, University of Michigan

Dr. Parmacek's pioneering research focuses on transcriptional programs regulating cardiovascular development. His seminal work has advanced understanding of the molecular and genetic basis of congenital heart disease, aortic disease, and atherosclerosis through innovative approaches in cardiovascular cell and molecular biology. His discoveries have significantly impacted the field of cardiovascular medicine.

His distinguished honors include:

• Established Investigator award from the American Heart Association
• Fellowship in the American Heart Association
• Fellowship in the American College of Cardiology
• Fellowship in the American College of Physicians
• Membership in the American Society of Clinical Investigation
• Membership in the American Association of Physicians

As an educator and leader, Dr. Parmacek served as Co-Director of the Cardiology fellowship training program at the University of Chicago (1992-1998) and mentored numerous trainees throughout his career. He has secured substantial research funding for cardiovascular investigations, though specific grant details are not provided in the source text. His leadership elevated Penn's Cardiovascular Medicine division to national prominence.

He directed the University of Pennsylvania Cardiovascular Institute from 2005-2017, fostering interdisciplinary collaboration among basic scientists and clinicians to accelerate cardiovascular research and therapeutic development across multiple laboratories and clinical teams.